Prosecution Insights
Last updated: July 17, 2026
Application No. 18/553,529

PROCESS FOR PRODUCING FURFURAL AND CATALYST FOR USE IN SAME

Non-Final OA §102§103
Filed
Sep 29, 2023
Priority
Apr 01, 2021 — AU 2021900972 +1 more
Examiner
VAJDA, KRISTIN ANN
Art Unit
1622
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Advanced Fuel Innovation Pty Ltd.
OA Round
1 (Non-Final)
84%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
95%
With Interview

Examiner Intelligence

Grants 84% — above average
84%
Career Allowance Rate
1351 granted / 1609 resolved
+24.0% vs TC avg
Moderate +11% lift
Without
With
+10.9%
Interview Lift
resolved cases with interview
Fast prosecutor
1y 9m
Avg Prosecution
40 currently pending
Career history
1641
Total Applications
across all art units

Statute-Specific Performance

§101
2.3%
-37.7% vs TC avg
§103
14.5%
-25.5% vs TC avg
§102
27.9%
-12.1% vs TC avg
§112
25.2%
-14.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1609 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claims 1-4, 6, 7, 9, 13, 14, 16-18, 20, 24, 25, 35, 36, 48, 50, 52, 54, and 61-63 are pending in the instant application. Claims 25, 35, 36, 48, 50, 52, and 54 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to non-elected subject matter. The withdrawn subject matter is patentably distinct from the elected subject matter as it differs in structure and element and would require separate search considerations. In addition, a reference which anticipates one group would not render obvious the other. Claims 1, 2, 9, 14, 17, 18, 20, 24, 61, and 62 are rejected. Claims 3, 4, 6, 7, 13, 16, and 63 are objected. Information Disclosure Statements The information disclosure statements filed on July 19, 2024, September 29, 2025, February 13, 2026, and April 10, 2026 have been considered and signed copies of form 1449 are enclosed herewith. Election/Restrictions The election of Group I, claims 1-4, 6, 7, 9, 13, 14, 16-18, 20, and 61-63, in the response filed on April 10, 2026 is acknowledged. The traversal is on the grounds: “Claim 24 incorporates the special technical feature of Claim 1 by its recitation of ‘producing furfural in accordance with claim 1’ and merely adds an additional step, Claims 1 and 24 have a special technical feature in common. Based on Example 17 and the common technical feature of Groups I and II, unity of invention exists between Groups I and II. Therefore, the division between Groups I and II should be withdrawn and Claims 1-4, 6, 7, 9, 13, 14, 16, 17, 18, 20, 24, and 61-63 be examined.” This argument is found to be fully persuasive and the restriction between Groups I and II has been withdrawn. The restriction requirement between Groups (I and II) and (III-VI) is still deemed proper and is hereby made final. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1, 2, 14, 18, and 20 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by US 2013/0317239 A1. US 2013/0317239 A1 discloses a process for producing 2-furaldehyde (i.e., furfural) from cellulose using zinc sulfate heptahydrate as a solid acid catalyst. See Example 13 and Table 2. In Example 13, a mixture of sulfolane and zinc sulfate heptahydrate under nitrogen was stirred and heated to 224 °C before a slurry of cellulose (25% by weight) was added. No steam is used. The 2-furaldehyde product was distilled off. Therefore, a process for producing furfural of the claims is anticipated by the reference. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 1, 2, 9, 14, 17, 18, 20, 24, 61, and 62 are rejected under 35 U.S.C. 103 as being unpatentable over US 2013/0317239 A1. US 2013/0317239 A1 discloses a process for producing 2-furaldehyde (i.e. furfural) from cellulose using zinc sulfate heptahydrate as a solid acid catalyst. See Example 13 and Table 2. In Example 13, a mixture of sulfolane and zinc sulfate heptahydrate under nitrogen was stirred and heated to 224 °C before a slurry of cellulose (25% by weight) was added. No steam is used. The 2-furaldehyde product was distilled off. It is disclosed in [0027] that the material can be wood, corncobs, bagasse, cotton, rice, or wheat. It is also disclosed that the reaction temperature may be 300 °C (see [0050]); that the obtained furfural may be converted to furan, tetrahydrofuran, or furfuryl alcohol (see [0071] – [0072]); that steam may be used (see [0049]); and the process may be formed as a continuous reaction (see [0053]). US 2013/0317239 A1 does not specifically disclose an example wherein the lignocellulosic material or fraction thereof is selected from the group listed in claim 9; the pyrolysis and/or production of furfural is carried out at a temperature in the range of from about 300 to about 500 °C; the furfural is converted into furfuryl alcohol, furoic acid, furan, tetrahydrofuran, levulinic acid, butadiene, hexamethylenediamine, tetrahydrofurfuryl alcohol, methyltetrahydrofuran or furfural-phenolic resin; the production of furfural is carried out in the presence of steam; or the process is carried out as a continuous or semi-continuous process. However, it would have been obvious to one of ordinary skill in the art at the time of the invention through routine experimentation to arrive at the processes of the claims in view of the process for producing 2-furaldehyde disclosed in the reference and that the obtained furfural may be converted to furan, tetrahydrofuran, or furfuryl alcohol with a reasonable expectation of success. The motivation would have been to find optimal processes for producing furfural and converting it into furan, tetrahydrofuran or furfuryl alcohol. Thus, a prima facie case of obviousness has been established. Claim Objections Claims 3, 4, 6, 7, 13, 16, and 63 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to KRISTIN ANN VAJDA whose telephone number is (571)270-5232. The examiner can normally be reached Mon-Fri 6:00-4:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, James Alstrum-Acevedo can be reached at 571-272-5548. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /KRISTIN A VAJDA/Primary Examiner, Art Unit 1622
Read full office action

Prosecution Timeline

Sep 29, 2023
Application Filed
Oct 05, 2024
Response after Non-Final Action
Jun 24, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12673930
THIOPHENE HSD17B13 INHIBITORS AND USES THEREOF
3y 5m to grant Granted Jul 07, 2026
Patent 12673938
CONJUGATES INCLUDING A DETECTABLE MOIETY
3y 4m to grant Granted Jul 07, 2026
Patent 12655115
SYNTHESIS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS
3y 1m to grant Granted Jun 16, 2026
Patent 12655146
PROCESSES FOR THE PREPARATION OF INHIBITORY COMPOUNDS
2y 6m to grant Granted Jun 16, 2026
Patent 12653768
POLYOL ESTER MIXTURE FOR USE AS VASELINE SUBSTITUTE
2y 5m to grant Granted Jun 16, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
84%
Grant Probability
95%
With Interview (+10.9%)
1y 9m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1609 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month